A retrospective study of clinical characteristics and therapeutic interventions in patients with GAD antibody-positive diabetes

A retrospective study of clinical characteristics and therapeutic interventions in patients with GAD antibody-positive diabetes - GAD-CARE Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000061447

Enrollment

3000

Registered

2026-05-11

Start date

2026-04-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients tested for anti-GAD antibodies at our hospital were included. Because the measurement method and reference range for anti-GAD antibodies were changed in December 2015, the study period was defined as the 10 years from January 2016 to December 2025.

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

Measure	Time frame
The prevalence of anti-GAD antibody-positive patients	—

Secondary

Measure	Time frame
Clinical characteristics of anti-GAD antibody-positive patients (including complications) Treatment interventions implemented in anti-GAD antibody-positive	—

Countries

Japan

Contacts

Public ContactHiroya Kondo

Kimitsu Chuo Hospital Department of Medicine, Division of Diabetes, Endocrinology and Metabolism

hiroya.k0526@gmail.com0438-36-1071

Outcome results